市場調查報告書
商品編碼
966744

急性非補償性心臟衰竭 (ADHF):市場分析,流行病學,市場預測 (2030年)

Acute Decompensated Heart Failure (ADHF) - Epidemiology Insight - 2030

出版日期: 按訂單生產 | 出版商: DelveInsight Business Research LLP | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球主要7個國家 - 美國,歐洲主要5個國家 (EU5:法國、德國、義大利、西班牙、英國),日本 - 的急性非補償性心臟衰竭 (ADHF)的疫情趨勢與今後的市場預測相關分析,疾病概要和市場基本結構,目前治療方法和未滿足需求,全球整體/各國的市場規模 (過去3年、今後11年份)等資訊彙整,為您概述為以下內容。

目錄

第1章 主要考察

第2章 急性非補償性心臟衰竭 (ADHF):摘要整理

第3章 急性非補償性心臟衰竭 (ADHF):疾病概要

  • 簡介
  • 徵兆與症狀
  • 病理生理學
  • 危險因素
  • 診斷標準

第4章 病患歷程

第5章 急性非補償性心臟衰竭 (ADHF)的流行病學與患者人口

  • 流行病學分析的要點
  • 假設和理論的根據:主要7個國家
  • 流行病學方案:主要7個國家
    • 急性非補償性心臟衰竭 (ADHF):主要7個國家的流行病學方案 (2017年∼2030年)
  • 美國的疫情趨勢
    • 美國國內的急性非補償性心臟衰竭 (ADHF)的流行病學方案 (2017年∼2030年)
  • 歐洲5個國家:各國疫情趨勢
    • 德國的疫情趨勢
    • 法國的疫情趨勢
    • 義大利的疫情趨勢
    • 西班牙的疫情趨勢
    • 英國的疫情趨勢
  • 日本的疫情趨勢
    • 日本國內的急性非補償性心臟衰竭 (ADHF)的流行病學方案 (2017年∼2030年)

第6章 治療流程,目前治療、診療方法

  • 急性非補償性心臟衰竭 (ADHF)的治療、管理方法
  • 急性非補償性心臟衰竭 (ADHF)的治療流程

第7章 產業專家 (KOL)的見解

第8章 未滿足需求

第9章 附錄

第10章:DelveInsight的服務內容

第11章 免責聲明

第12章:關於DelveInsight

目錄
Product Code: DIEI1019

DelveInsight's 'Acute Decompensated Heart Failure (ADHF) - Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical and forecasted Acute Decompensated Heart Failure (ADHF) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2017-2030

Acute Decompensated Heart Failure (ADHF) Understanding

The DelveInsight Acute Decompensated Heart Failure (ADHF) epidemiology report gives a thorough understanding of the Acute Decompensated Heart Failure (ADHF) by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Acute Decompensated Heart Failure (ADHF) in the US, Europe, and Japan. The report covers the detailed information of the Acute Decompensated Heart Failure (ADHF) epidemiology scenario in seven major countries (US, EU5, and Japan).

Acute Decompensated Heart Failure (ADHF) Epidemiology Perspective by DelveInsight

The Acute Decompensated Heart Failure (ADHF) epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Acute Decompensated Heart Failure (ADHF) epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Acute Decompensated Heart Failure (ADHF) epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Acute Decompensated Heart Failure (ADHF) Detailed Epidemiology Segmentation

The Acute Decompensated Heart Failure (ADHF) epidemiology covered in the report provides historical as well as forecasted Acute Decompensated Heart Failure (ADHF) epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan from 2017 to 2030.

The DelveInsight Acute Decompensated Heart Failure (ADHF) report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

Scope of the Report:

  • The Acute Decompensated Heart Failure (ADHF) report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The Acute Decompensated Heart Failure (ADHF) Epidemiology Report and Model provide an overview of the risk factors and global trends of Acute Decompensated Heart Failure (ADHF) in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight about the historical and forecasted patient pool of Acute Decompensated Heart Failure (ADHF) in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Acute Decompensated Heart Failure (ADHF)
  • The report provides the segmentation of the Acute Decompensated Heart Failure (ADHF) epidemiology

Report Highlights:

  • 11-Year Forecast of Acute Decompensated Heart Failure (ADHF) epidemiology
  • 7MM Coverage
  • Total Cases of Acute Decompensated Heart Failure (ADHF)
  • Total Cases of Acute Decompensated Heart Failure (ADHF) according to segmentation
  • Diagnosed cases of Acute Decompensated Heart Failure (ADHF)

KOL- Views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Acute Decompensated Heart Failure (ADHF) ?
  • What are the key findings pertaining to the Acute Decompensated Heart Failure (ADHF) epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2017-2030)?
  • What would be the total number of patients of Acute Decompensated Heart Failure (ADHF) across the 7MM during the forecast period (2017-2030)?
  • Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017-2030)?
  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017-2030)?
  • What is the disease risk, burden and unmet needs of the Acute Decompensated Heart Failure (ADHF) ?
  • What are the currently available treatments of Acute Decompensated Heart Failure (ADHF) ?

Reasons to buy:

  • The Acute Decompensated Heart Failure (ADHF) Epidemiology report will allow the user to -
  • Develop business strategies by understanding the trends shaping and driving the global Acute Decompensated Heart Failure (ADHF) market
  • Quantify patient populations in the global Acute Decompensated Heart Failure (ADHF) market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Acute Decompensated Heart Failure (ADHF) therapeutics in each of the markets covered
  • Understand the magnitude of Acute Decompensated Heart Failure (ADHF) population by its epidemiology
  • The Acute Decompensated Heart Failure (ADHF) Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

Table of Contents

1. Key Insights

2. Executive Summary of Acute Decompensated Heart Failure (ADHF)

3. Acute Decompensated Heart Failure (ADHF) : Disease Background and Overview

  • 3.1. Introduction
  • 3.2. Sign and Symptoms
  • 3.3. Pathophysiology
  • 3.4. Risk Factors
  • 3.5. Diagnosis

4. Patient Journey

5. Epidemiology and Patient Population

  • 5.1. Epidemiology Key Findings
  • 5.2. Assumptions and Rationale: 7MM
  • 5.3. Epidemiology Scenario: 7MM
    • 5.3.1. Acute Decompensated Heart Failure (ADHF) Epidemiology Scenario in the 7MM (2017- 2030)
  • 5.4. United States Epidemiology
    • 5.4.1. Acute Decompensated Heart Failure (ADHF) Epidemiology Scenario in the United States (2017- 2030)
  • 5.5. EU-5 Country-wise Epidemiology
    • 5.5.1. Germany Epidemiology
      • 5.5.1.1. Acute Decompensated Heart Failure (ADHF) Epidemiology Scenario in Germany (2017- 2030)
    • 5.5.2. France Epidemiology
      • 5.5.2.1. Acute Decompensated Heart Failure (ADHF) Epidemiology Scenario in France (2017- 2030)
    • 5.5.3. Italy Epidemiology
      • 5.5.3.1. Acute Decompensated Heart Failure (ADHF) Epidemiology Scenario in Italy (2017- 2030)
    • 5.5.4. Spain Epidemiology
      • 5.5.4.1. Acute Decompensated Heart Failure (ADHF) Epidemiology Scenario in Spain (2017- 2030)
    • 5.5.5. United Kingdom Epidemiology
      • 5.5.5.1. Acute Decompensated Heart Failure (ADHF) Epidemiology Scenario in the United Kingdom (2017-2030)
  • 5.6. Japan Epidemiology
    • 5.6.1. Acute Decompensated Heart Failure (ADHF) Epidemiology Scenario in Japan (2017- 2030)

6. Treatment Algorithm, Current Treatment, and Medical Practices

  • 6.1. Acute Decompensated Heart Failure (ADHF) Treatment and Management
  • 6.2. Acute Decompensated Heart Failure (ADHF) Treatment Algorithm

7. KOL Views

8. Unmet Needs

9. Appendix

  • 9.1. Bibliography
  • 9.2. Report Methodology

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

The table of contents is not exhaustive; will be provided in the final report

List of Tables

  • Table 1: Acute Decompensated Heart Failure (ADHF) Epidemiology in 7MM (2017-2030)
  • Table 2: Acute Decompensated Heart Failure (ADHF) Diagnosed and Treatable Cases in 7MM (2017-2030)
  • Table 3: Acute Decompensated Heart Failure (ADHF) Epidemiology in the United States (2017-2030)
  • Table 4: Acute Decompensated Heart Failure (ADHF) Diagnosed and Treatable Cases in the United States (2017-2030)
  • Table 5: Acute Decompensated Heart Failure (ADHF) Epidemiology in Germany (2017-2030)
  • Table 6: Acute Decompensated Heart Failure (ADHF) Diagnosed and Treatable Cases in Germany (2017-2030)
  • Table 7: Acute Decompensated Heart Failure (ADHF) Epidemiology in France (2017-2030)
  • Table 8: Acute Decompensated Heart Failure (ADHF) Diagnosed and Treatable Cases in France (2017-2030)
  • Table 9: Acute Decompensated Heart Failure (ADHF) Epidemiology in Italy (2017-2030)
  • Table 10: Acute Decompensated Heart Failure (ADHF) Diagnosed and Treatable Cases in Italy (2017-2030)
  • Table 11: Acute Decompensated Heart Failure (ADHF) Epidemiology in Spain (2017-2030)
  • Table 12: Acute Decompensated Heart Failure (ADHF) Diagnosed and Treatable Cases in Spain (2017-2030)
  • Table 13: Acute Decompensated Heart Failure (ADHF) Epidemiology in the United Kingdom (2017-2030)
  • Table 14: Acute Decompensated Heart Failure (ADHF) Diagnosed and Treatable Cases in the United Kingdom (2017-2030)
  • Table 15: Acute Decompensated Heart Failure (ADHF) Epidemiology in Japan (2017-2030)
  • Table 16: Acute Decompensated Heart Failure (ADHF) Diagnosed and Treatable Cases in Japan (2017-2030)

List of Figures

  • Figure 1: Acute Decompensated Heart Failure (ADHF) Epidemiology in 7MM (2017-2030)
  • Figure 2: Acute Decompensated Heart Failure (ADHF) Diagnosed and Treatable Cases in 7MM (2017-2030)
  • Figure 3: Acute Decompensated Heart Failure (ADHF) Epidemiology in the United States (2017-2030)
  • Figure 4: Acute Decompensated Heart Failure (ADHF) Diagnosed and Treatable Cases in the United States (2017-2030)
  • Figure 5: Acute Decompensated Heart Failure (ADHF) Epidemiology in Germany (2017-2030)
  • Figure 6: Acute Decompensated Heart Failure (ADHF) Diagnosed and Treatable Cases in Germany (2017-2030)
  • Figure 7: Acute Decompensated Heart Failure (ADHF) Epidemiology in France (2017-2030)
  • Figure 8: Acute Decompensated Heart Failure (ADHF) Diagnosed and Treatable Cases in France (2017-2030)
  • Figure 9: Acute Decompensated Heart Failure (ADHF) Epidemiology in Italy (2017-2030)
  • Figure 10: Acute Decompensated Heart Failure (ADHF) Diagnosed and Treatable Cases in Italy (2017-2030)
  • Figure 11: Acute Decompensated Heart Failure (ADHF) Epidemiology in Spain (2017-2030)
  • Figure 12: Acute Decompensated Heart Failure (ADHF) Diagnosed and Treatable Cases in Spain (2017-2030)
  • Figure 13: Acute Decompensated Heart Failure (ADHF) Epidemiology in the United Kingdom (2017-2030)
  • Figure 14: Acute Decompensated Heart Failure (ADHF) Diagnosed and Treatable Cases in the United Kingdom (2017-2030)
  • Figure 15: Acute Decompensated Heart Failure (ADHF) Epidemiology in Japan (2017-2030)
  • Figure 16: Acute Decompensated Heart Failure (ADHF) Diagnosed and Treatable Cases in Japan (2017-2030)

The table of contents is not exhaustive; will be provided in the final report